Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

Brain Research

Volumn 864, Issue 2, 2000, Pages 281-290

  Mohanakumar, Kochupurackal P ^a   Muralikrishnan, Dhanasekharan ^a   Thomas, Bobby ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Dopamine depletion; Free radical scavenger; Glutathione; Hydroxyl radicals; MPTP; Neuroprotection; Nucleus caudatus putamen; Salicylic acid

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMINE OXIDASE (FLAVIN CONTAINING); GLUTATHIONE; SALICYLATE SODIUM; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; FEMALE; MALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BEHAVIOR, ANIMAL; CATALEPSY; CYCLOOXYGENASE INHIBITORS; DOPAMINE; DOPAMINE AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; FREE RADICAL SCAVENGERS; GENTISATES; GLUTATHIONE; HOMOVANILLIC ACID; HYDROXYBENZOIC ACIDS; HYDROXYL RADICAL; MALE; MICE; MICE, INBRED BALB C; MONOAMINE OXIDASE; MPTP POISONING; NEOSTRIATUM; NEUROPROTECTIVE AGENTS; SODIUM SALICYLATE; SUBSTANTIA NIGRA;

EID: 0034640430     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02189-2     Document Type: Article

References (56)

1. S. Abramson, H. Korchak, R. Ludewig, H. Edelson, K. Haines, R.I. Levin, R. Herman, L. Rider, S. Kimmel, G. Weissmann, Modes of action of aspirin-like drugs, Proc. Natl. Acad. Sci. USA 82 (1985) 7227-7231.
2. N. Aubin, O. Curet, A. Deffois, C. Carter, Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice, J. Neurochem. 71 (1998) 1635-1642.
3. M.S. Baker, J.M. Gebicki, The effect of pH on yields of hydroxyl radicals produced from superoxide by potential biological iron chelators, Arch. Biochem. Biophys. 246 (1986) 581-588.
4. R. Blakytny, J.J. Harding, Prevention of cataract in diabetic rats by aspirin, paracetamol (actaminophen) and ibuprofen, Exp. Eye Res. 54 (1992) 509-518.
5. G.C. Chan, T.R. Hinds, S. Impey, D.R. Storm, Hippocampal neurotoxicity of delta-9-tetrahydrocannabinol, J. Neurosci. 18 (1998) 5322-5332.
6. C.C. Chiueh, H. Miyake, M.T. Peng, Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlining mechanisms involved in MPTP-induced parkinsonism, Adv. Neurol. 60 (1993) 251-258.
7. V.H. Cohn, J. Lyle, A fluorimetric assay for glutathione, Anal. Biochem. 14 (1966) 434-440.
8. C. Coudray, M. Talla, S. Martin, M. Fatome, A. Favier, High-performance liquid chromatography-electrochemical determination of salicylate hydroxylation products as an in vivo marker of oxidative stress, Anal. Biochem. 227 (1995) 101-111.
9. +) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat, Neurosci. Lett. 161 (1993) 121-123.
10. G.G. Duggin, Combination analgesic-induced kidney disease: the Australian experience, Am. J. Kidney Dis. 28 (1996) S39-S47.
11. M. Ebadi, S.K. Srinivasan, M.D. Baxi, Oxidative stress and anti-oxidant therapy in Parkinson's disease, Prog. Neurobiol. 48 (1996) 1-19.
12. R.A. Floyd, J.J. Watson, P.K. Wong, Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products, J. Biochem. Biophys. Methods 10 (1984) 221-235.
13. E. Frati, A.M. Khatib, P. Front, P.F. Aprile, D.R. Mitrovic, Degradation of hyaluronic acid by photosensitized riboflavin in vitro. Modulation of the effect by transition metals, radical quenchers, and metal chelators, Free Radie. Biol. Med. 22 (1997) 1139-1144.
14. M. Grilli, M. Pizzi, M. Memo, P. Spano, Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation, Science 274 (1996) 1383-1385.
15. M. Grootveld, B. Halliwell, Aromatic hydroxylation as a potential measure of hydroxyl radical formation in vivo. Identification of hydroxylated derivative of salicylate in human body fluids, Biochem. J. 237 (1986) 499-504.
16. J.M.C. Gutteridge, Ferrous-salt-promoted damage to deoxyribose and benzoate, Biochem. J. 243 (1987) 709-714.
17. B. Halliwell, Superoxide-dependent formation of hydroxyl radicals in the presence of iron chelates, FEBS Lett. 92 (1978) 321-326.
18. B. Halliwell, M. Grootveld, J.M.C. Gutteridge, Methods for the measurement of hydroxyl radicals in biochemical systems: deoxyribose degradation and aromatic hydroxylation, Methods Biochem. Anal. 33 (1989) 59-90.
19. B. Halliwell, H. Kaur, M. Ingelman-Sundberg, Hydroxylation of salicylate as an assay for hydroxyl radicals: A cautionary note, Free Radie. Biol. Med. 10 (1991) 439-441.
20. J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Rudden, R.G. Gilman (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th Edition, McGraw-Hill, New York, 1996, p. 1905.
21. T.G. Hastings, Enzymatic oxidation of dopamine: the role of prostaglandin-H synthase, J. Neurochem. 64 (1995) 919-924.
22. R.E. Heikkila, L. Manzino, F.S. Cabbat, R.C. Duvoisin, Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors, Nature 311 (1984) 467-469.
23. R. Joseph, D.M. Saroff, J.R. Delfs, Platelets secretory products have a damaging effect on neurons, Neurosci. Lett. 135 (1992) 153-158.
24. A. Kanazawa, T. Kondo, Hydroxyl radicals generation and post-ischemic reperfusion brain damage implications for neuroprotection, No to Shinkei (Brain Nerve) 48 (1996) 567-572.
25. M. Kataoka, K. Tonooka, T. Ando, K. Imai, T. Almato, Hydroxyl radicals scavenging activity of nonsteroidal anti-inflammatory drugs, Free Radie. Res. 27 (1997) 419-427.
26. H.C. Kim, D.Y. Choi, W.K. Jhoo, D.W. Lee, C.H. Koo, C. Kim, Aspalatone, a new anti-platelet agent, attenuates the neurotoxicity induced by kainic acid in the rat, Life Sci. 61 (1997) 373-381.
27. M. Kirkova, E. Ivancheva, E. Russanov, Lipid peroxidation and antioxidant enzyme activity in aspirin-treated rats, Gen. Pharmacol. 26 (1995) 613-617.
28. T. Kondo, T. Ito, Y. Sugita, Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum, Ann. NY Acad. Sci. 738 (1994) 222-229.
29. N. Lermontova, O. Drany, D. Dobrota, V. Mezesova, V. Lombardi, S. Bachurin, Relative resistance of rabbits to MPTP neurotoxicity, Mol. Chem. Neuropathol. 25 (1995) 135-141.
30. O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
31. X. Luo, D.C. Lehotay, Determination of hydroxyl radicals using salicylate as a trapping agent by gas chromatography-mass spectrometry, Clin. Biochem. 31 (1997) 41-46.
32. S.P. Markey, J.N. Johannessen, C.C. Chiueh, R.S. Burns, M.A. Herkenham, Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism, Nature 311 (1984) 464-467.
33. M.B. Mattammal, R. Strong, V.M. Lakshmi, H.D. Chung, A.H. Stephenson, Prostglandin-H synthetase-mediated metabolism of dopamine: implication for Parkinson's disease, J. Neurochem. 64 (1995) 1645-1654.
34. N. Mitra, K.P. Mohanakumar, D.K. Ganguly, Dissociation of serotoninergic and dopaminergic components in acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice, Brain Res. Bull. 28 (1992) 355-364.
35. N. Mitra, K.P. Mohanakumar, D.K. Ganguly, Resistance of golden hamster to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Relationship with low levels of regional monoamine oxidase-B, J. Neurochem. 62 (1994) 1906-1912.
36. K.P. Mohanakumar, H.W.M. Steinbusch, Hydroxyl radicals and nitric oxide in neurotoxicity and neuroprotection, J. Chem. Neuroanat. 14 (1998) 125-127.
37. K.P. Mohanakumar, A. De Bartolomeis, R.M. Wu, K.J. Yeh, L.M. Sternberger, S.Y. Peng, D.L. Murphy, C.C. Chiueh, Ferrous-citrate complex and nigral degeneration: Evidence for free radical formation and lipid peroxidation, Ann. NY Acad. Sci. 738 (1994) 392-399.
38. K.P. Mohanakumar, I. Hanbauer, C.C. Chiueh, Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity, J. Chem. Neuroanat. 14 (1998) 195-205.
39. A. Morinan, H.M. Garratt, An improved fluorimetric assay for brain monoamine oxidase, J. Pharmacol. Methods 13 (1985) 213-223.
40. D. Muralikrishnan, K.P. Mohanakumar, Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice, FASEB J. 12 (1998) 905-912.
41. T. Ohkuwa, Y. Sato, M. Naoi, Hydroxyl radical formation in diabetic rats induced by streptozotocin, Life Sci. 56 (1995) 1789-1798.
42. M. Palkovits, M.J. Brownstein, Microdissection of brain areas by punch techniques, in: A.C. Cuello (Ed.), Brain Microdissection Techniques, Wiley, New York, 1983, pp. 31-36.
43. C.A. Piantadosi, J. Zhang, Mitochondrial generation of reactive oxygen species after brain ischemia in the rat, Stroke 27 (1996) 327-331.
44. E. Picano, M.P. Abbracchio, European stroke prevented study. II. Results. Serendipitous demonstration of neuroprotection induced by endogenous adenosine accumulation?, Trends Pharmacol. Sci. 19 (1998) 14-16.
45. D.M. Radzik, D.A. Roston, P.T. Kissinger, Determination of hydroxylated aromatic compounds produced in a superoxide-dependent formation of hydroxyl radicals by liquid chromatography/electrochemistry, Anal. Biochem. 131 (1983) 458-464.
46. K.O. Rainsford, Aspirin and the salicylates, in: A.G. Gilman, L.S. Goodman, A. Gilman, S.E. Mayer, K.L. Melmon (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, 1985, pp. 617-657.
47. R. Richmond, B. Halliwell, J. Chauhan, A. Darbre, Superoxide-dependent formation of hydroxyl radicals: Detection of hydroxyl radicals by the hydroxylation of aromatic compounds, Anal. Biochem. 118 (1981) 328-335.
48. H. Sershen, M.E. Reith, A. Hashim, A. Lajtha, Protection against l-methyl-4-phenyl 1,2,3,6-tetrahydropyridine by the antioxidant ascorbic acid, Neuropharmacology 24 (1985) 1257-1259.
49. K. Siemers, Recent progress in the treatment of Parkinson's disease, Comp. Ther. 18 (1992) 20-24.
50. B. Thomas, D. Muralikrishnan, K.P. Mohanakumar, In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice, Brain Res. 852 (2000) 221-224.
51. J.R. Vane, R. Bolting, Inflammation and mechanism of action of anti-inflammatory drugs, FASEB J. 1 (1987) 89-96.
52. F.B. Weihmuller, M. Hadjiconstantinou, J.P. Bruno, Acute stress or neuroleptics elicit sensorimotor deficits in MPTP-treated mice, Neurosci. Lett. 85 (1988) 137-142.
53. G. Weissmann, After more than 200 years, the mechanisms by which this vulnerable drug and its relatives achieve their wide range of effects have yet to be fully elucidated, Sci. Am. 264 (1991) 58-64.
54. + in vivo, Eur. J. Pharmacol. 243 (1993) 241-247.
55. C.S. Yang, P.J. Tsai, N.N. Lin, L. Liu, J.S. Kuo, Elevated extracellular glutamate levels increased the formation of hydroxyl radical in the striatum of anesthetized rat, Free Radie. Biol. Med. 19 (1995) 453-459.
56. J.L. Zheng, W.Q. Gao, Differential damage to auditory neurons and hair cells by ototoxin and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures, Eur. J. Neurosci. 8 (1996) 1897-1905.